Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2027

Microchip posts 42% revenue growth and record profits, with robust guidance for next quarter.

What the company is saying

Microchip Technology Incorporated is highlighting a 42.2% year-over-year increase in net sales to $1.622 billion for the quarter ended September 30, 2026, and a 9.2% sequential rise. The company frames this as broad-based growth, emphasizing industrial and data center applications, and points to 24 PCIe Gen6 switch and retimer design wins in data center, up from 12 in the prior quarter. Management, led by CEO Steve Sanghi and CFO Eric Bjornholt, stresses operational discipline, noting non-GAAP operating expenses grew well below net sales, supporting higher profitability. The narrative is confident, citing robust bookings, a book-to-bill ratio well above one, and a steady cadence of new product introductions. The company also addresses seasonality, guiding for December quarter net sales between $1.573 billion and $1.638 billion, with a midpoint representing 35.4% year-over-year growth and outperforming typical seasonal declines by 5% to 7% after adjusting for $53 million of infrequent revenue items in the September quarter. Dividend declarations are specific: $0.455 per common share payable December 8, 2026, and $18.750 per Series A Preferred share payable December 15, 2026. The announcement also notes Victor Peng's resignation from the Board due to external commitments.

What the data suggests

The disclosed numbers show a sharp improvement in financial performance. Net sales reached $1,621.5 million, up from $1,140.4 million a year earlier. GAAP net income attributable to common stockholders rose to $373.6 million ($0.68 per diluted share) from $13.9 million ($0.03 per diluted share) the previous year. Non-GAAP net income jumped to $559.2 million ($0.97 per diluted share) from $199.1 million ($0.35 per diluted share). Gross profit margins improved to 65.9% GAAP and 66.5% non-GAAP. Operating income increased to $464.5 million GAAP and $639.9 million non-GAAP. The company declared dividends of $0.455 per common share and $18.750 per Series A Preferred share. Guidance for the December quarter projects net sales between $1.573 billion and $1.638 billion, with gross margin expected at 62.9%–63.9% GAAP and 64.0%–65.0% non-GAAP. Capital expenditures are forecast at $35 million for the December quarter and $100 million for fiscal 2027. The company is pausing most factory expansions but is selectively adding capacity and R&D equipment. While claims of broad-based growth and robust bookings are not quantified at the segment level, the overall financial trajectory is strongly positive.

Analysis

The announcement's tone is positive but proportionate to the substantial realised financial and operational progress disclosed. The majority of key claims are realised facts, including a 42.2% year-over-year increase in net sales, significant improvements in GAAP and non-GAAP net income, and concrete design win metrics. Profitability metrics (net income, operating income, gross margin) are fully disclosed alongside revenue, satisfying the completeness rule for a strong_positive signal. Forward-looking statements are limited to next-quarter guidance and modest capital expenditure plans, with no exaggerated claims about long-term transformation or outsized future benefits. The capital outlay is moderate and paired with immediate operational needs, not speculative projects. Qualitative statements about broad-based growth and robust bookings are not numerically substantiated, but do not materially inflate the overall signal given the strength of the reported results.

Risk flags

• ●Supply chain risk is elevated, with management noting lengthening lead times and the need to secure additional wafer allocation. This could constrain future revenue growth or margin if not addressed.
• ●The September quarter included $53 million of infrequent revenue items that will not recur in the December quarter, potentially masking underlying sequential trends and making future comparisons less straightforward.
• ●Capital investment has been reduced and most factory expansions are paused, which could limit the company's ability to respond to a sudden surge in demand or to capitalize on longer-term growth opportunities.
• ●The resignation of Victor Peng from the Board removes a director with external CEO experience, which could impact board-level strategic oversight, though no immediate operational disruption is indicated.

Bottom line

Microchip delivered a standout quarter with 42% year-over-year revenue growth, record net income, and improved margins, all supported by robust bookings and design wins in key markets. The company is guiding for continued strong performance in the December quarter, with net sales expected to remain near current levels and gross margins holding steady. Dividend payments are secure, and capital expenditures are being tightly managed, reflecting a disciplined approach in a cautious macro environment. The main risks are supply chain constraints and the non-recurrence of $53 million in one-time revenue, which could affect sequential comparisons. Investors should focus on the sustainability of demand, the company's ability to secure supply, and any updates on capital allocation or restructuring, including the potential sale of the Fab 2 facility. The most important takeaway is that Microchip's current operational and financial momentum is strong, with near-term visibility and credible execution.

Announcement summary

(NASDAQ: MCHP) Microchip Technology Incorporated reported results for the three months ended September 30, 2026, with net sales of $1.622 billion, representing a 42.2% year-over-year increase and a 9.2% sequential increase. Steve Sanghi, President and Chief Executive Officer, stated that growth was broad-based across end markets, particularly driven by industrial and data center applications, and highlighted 24 PCIe Gen6 switch and retimer design wins in data center, up from 12 at the end of the June quarter. Bookings remained robust with a book-to-bill ratio well above one. The company introduced new products and technologies across data center, aerospace and defense, automotive, and industrial applications. Eric Bjornholt, Corporate Senior Vice President and Chief Financial Officer, noted that non-GAAP operating expenses grew well below net sales, supporting higher profitability. GAAP gross profit for the quarter was $1,068.0 million (65.9% of net sales), and non-GAAP gross profit was $1,077.8 million (66.5%). GAAP operating income was $464.5 million (28.6%), and non-GAAP operating income was $639.9 million (39.5%). GAAP net income attributable to common stockholders was $373.6 million, or $0.68 per diluted share, up from $13.9 million, or $0.03 per diluted share, in the prior year's second fiscal quarter. Non-GAAP net income was $559.2 million, or $0.97 per diluted share, up from $199.1 million, or $0.35 per diluted share, in the prior year's second fiscal quarter. The company declared a quarterly cash dividend on its common stock of $0.455 per share, payable on December 8, 2026, to stockholders of record on November 23, 2026. The Board also declared a quarterly cash dividend on the 7.50% Series A Mandatory Convertible Preferred Stock of $18.750 per share ($0.9375 per depositary share), payable on December 15, 2026, to stockholders of record on December 1, 2026. Victor Peng informed the Board of Directors of his decision to step down from the Board due to other commitments, including serving as Chief Executive Officer of PsiQuantum. For the third quarter of fiscal 2027, Microchip provided guidance for net sales between $1.573 billion and $1.638 billion. GAAP gross margin is expected to be between 62.9% and 63.9%, and non-GAAP gross margin between 64.0% and 65.0%. GAAP operating expenses are expected to be 36.7% to 37.4% of net sales, and non-GAAP operating expenses 26.5% to 27.0%. GAAP operating income is expected to be 25.5% to 27.2% of net sales, and non-GAAP operating income 37.0% to 38.5%. GAAP net income attributable to common stockholders is expected to be $258.1 million to $278.0 million, and non-GAAP net income attributable to common stockholders is expected to be $498.8 million to $545.1 million. Diluted net income per common share is expected to be $0.47 to $0.50 GAAP and $0.87 to $0.95 non-GAAP. Capital expenditures for the quarter ending December 31, 2026, are expected to be about $35 million, and for all of fiscal 2027, approximately $100 million. The company has paused most factory expansion actions and reduced planned capital investments through fiscal 2027, but is selectively adding capital equipment to expand production capacity and research and development. Lead times are lengthening across the supply chain, and Microchip is working to expand capacity and secure additional wafer allocation. The company’s GAAP guidance excludes the impact of any potential gains or charges related to ongoing evaluation of restructuring activities, including the sale of the Fab 2 wafer fabrication facility in Tempe, Arizona.

Disagree with this article?